BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3106791)

  • 1. c-myc gene expression and interleukin-2 receptor levels in cloned human CD2+,CD3+ and CD2+,CD3- lymphocytes.
    Gravekamp C; van den Bulck LP; Vijg J; van de Griend RJ; Bolhuis RL
    Nat Immun Cell Growth Regul; 1987; 6(1):28-36. PubMed ID: 3106791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
    J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous increased expression of E-rosette receptor (CD2, T11) and T cell growth factor receptor on human T lymphocytes during activation.
    Redelman D
    Cytometry; 1987 Mar; 8(2):170-83. PubMed ID: 3107949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the accessory cell in mitogen-stimulated human T cell gene expression.
    Kern JA; Reed JC; Daniele RP; Nowell PC
    J Immunol; 1986 Aug; 137(3):764-9. PubMed ID: 3088109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential production of interleukin-3 in human T lymphocytes following either CD3 or CD2 receptor activation.
    Dilloo D; Dirksen U; Schneider M; Zessack N; Buttlies B; Levitt L; Burdach S
    Exp Hematol; 1996 Mar; 24(4):537-43. PubMed ID: 8608804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
    Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction and regulation of CD2 mRNA in human lymphocytes.
    Malter JS; Reed JC; Kamoun M
    J Immunol; 1988 May; 140(9):3233-6. PubMed ID: 2896216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25).
    Redelman D
    Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-specific T cell unresponsiveness in cloned helper T cells mediated via the CD2 or CD3/Ti receptor pathways.
    Lamb JR; Zanders ED; Sewell W; Crumpton MJ; Feldmann M; Owen MJ
    Eur J Immunol; 1987 Nov; 17(11):1641-4. PubMed ID: 2960547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule.
    Gerli R; Agea E; Muscat C; Ercolani R; Bistoni O; Tognellini R; Mariggió MA; Spinozzi F; Bertotto A
    Cell Immunol; 1994 Apr; 155(1):205-18. PubMed ID: 7909498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggering of cytotoxic T lymphocytes and NK cells via the Tp103 pathway is dependent on the expression of the T cell receptor/CD3 complex.
    Fleischer B; Sturm E; De Vries JE; Spits H
    J Immunol; 1988 Aug; 141(4):1103-7. PubMed ID: 2840462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell activation. V. Anti-major histocompatibility complex class I antibody-induced activation and clonal abortion in Jurkat T-leukaemic cells.
    Claesson MH; Dissing S; Tscherning T; Geisler C
    Immunology; 1993 Mar; 78(3):444-8. PubMed ID: 8097490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the CD2 alternate pathway of T cell activation by CD3. Evidence for heterologous desensitization.
    Holter W; Majdic O; Stockinger H; Howard BH; Knapp W
    J Immunol; 1988 Feb; 140(4):1043-6. PubMed ID: 2893822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B.
    Costello R; Lipcey C; Algarté M; Cerdan C; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Apr; 4(4):329-39. PubMed ID: 8098618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies.
    Yang SY; Rhee S; Welte K; Dupont B
    J Immunol; 1988 Apr; 140(7):2115-20. PubMed ID: 3258328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
    Cleveland JL; Rapp UR; Farrar WL
    J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-fos, c-myc and IL-2R mRNA expression in PHA activated T lymphocytes treated with a monoclonal anti-HLA class I antibody (MAb 01.65).
    Selvatici R; Rubini M; Orlando P; Balboni A; Gandini E
    Biochem Int; 1990 Nov; 22(3):397-403. PubMed ID: 2076099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes.
    Karmali R; Hewison M; Rayment N; Farrow SM; Brennan A; Katz DR; O'Riordan JL
    Immunology; 1991 Dec; 74(4):589-93. PubMed ID: 1783418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.